Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-323907
Filing Date
2025-12-18
Accepted
2025-12-18 10:17:15
Documents
3
Period of Report
2025-12-18

Document Format Files

Seq Description Document Type Size
1 PRE 14A preliminary_proxy_decemb.htm PRE 14A 571723
2 GRAPHIC img217670610_0.jpg GRAPHIC 134294
3 GRAPHIC img217670610_1.jpg GRAPHIC 86151
  Complete submission text file 0001193125-25-323907.txt   876767
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41934 | Film No.: 251581632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)